Results from the CLARITY Study: a Phase III, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Oral Cladribine in Relapsing-Remitting Multiple Sclerosis (RRMS)

Gavin Giovannoni, Giacomo P. Comi, SD Cook, K Rammohan, Peter Rieckmann

Data up to Jan 2025

Published2009

Citations6

References0

Fields

Medicine Chemistry Internal medicine Pathology Psychiatry

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Results from the CLARITY Study: a Phase III, Randomized, Double-Blind Study to Evaluate… (2009) | Metascience Observatory Explorer